MR编号 | SE/H/0180/001 |
---|
药品名称 | Relenza |
---|
活性成分 | |
---|
剂型 | Inhalation powder, pre-dispensed |
---|
上市许可持有人 | GlaxoSmithKline AB, Sweden |
---|
参考成员国 - 产品名称 | Sweden (SE) |
---|
互认成员国 - 产品名称 | - Germany (DE)
- Denmark (DK)
- Belgium (BE)
- Luxembourg (LU)
- Iceland (IS)
- Ireland (IE)
- France (FR)
- Spain (ES)
- Italy (IT)
- Greece (GR)
- Norway (NO)
- Finland (FI)
- Poland (PL)
Relenza - Latvia (LV)
Relenza 5 mg/dose, inhalation powder, pre-dispensed - Lithuania (LT)
Relenza 5 mg/dozėje inhaliacinai milteliai - Hungary (HU)
- Czechia (CZ)
- Slovakia (SK)
Relenza - Slovenia (SI)
- Malta (MT)
- Portugal (PT)
- Netherlands (NL)
- Austria (AT)
- Estonia (EE)
|
---|
许可日期 | 1999/06/01 |
---|
最近更新日期 | 2024/12/18 |
---|
药物ATC编码 | |
---|
申请类型 | - TypeLevel1:New Active Substance
- TypeLevel2:Initial Application
- TypeLevel3:Full Dossier Article 4.8 Di 65/65
- TypeLevel4:Chemical Substance
- TypeLevel5:Prescription Only
|
---|
附件文件下载 | |
---|
市场状态 | Positive |
---|